Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.7971
BATS BZX Real-Time Price
As of 2:48pm ET
 +0.0192 / +2.47%
Today’s Change
0.76
Today|||52-Week Range
1.47
-30.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$82.3M

Company Description

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A. Palace in April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
900 East Evelyn Avenue
Campbell California 95008
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders5.75%
Other institutional31.03%
Individual stakeholders24.29%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Mark K. OkiChief Financial & Accounting Officer
Santosh T. VargheseChief Medical Officer
Ted BromanVice President-Chemistry, Manufacturing & Control
Sandra E. WellsVice President-Patents & Assistant General Counsel